Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21)
The summary for the Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21): -Purpose. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourage grant applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed project must be on the basic biology, prevention, and/or treatment of liver cancer. Applications solely concerned with population studies and epidemiology will not be supported in connection with this FOA. -Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with two FOAs of similar scientific scope: (1) PA-08-243, for research projects using the R01 mechanism; and (2) PAR-08-245, for program project grants under the P01 mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known
Federal Grant Title: | Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-08-244 |
Type of Funding: | Grant |
CFDA Numbers: | 93.27393.286 |
CFDA Descriptions: | Alcohol Research Programs 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Sep 07, 2011 |
Posted Date: | Aug 19, 2008 |
Creation Date: | Aug 19, 2008 |
Archive Date: | Dec 05, 2008 |
Total Program Funding: | |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | 93.393 -- Cancer Cause and Prevention Research |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments Private institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession; Units of Local Governments.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster